Prestige Consumer Healthcare Inc.
NYSE:PBHMedical - Distribution
+$0.23 today
- Market cap
- $2.40B
- Beta
- 0.35
- P/E (TTM)
- 11.6
- EPS (TTM)
- $4.01
Volume 0.62M
Average 0.67M
PBH Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Prestige Consumer Healthcare Inc.NYSE: PBH
Operating Expenses · Q1 FY2027 · quarter ended Jun 2026
Operating expenses growth accelerates
Q1 FY2027 operating expenses of $83.67M rose 32.0% year over year, ahead of the +1.9% change in trailing-twelve-month operating expenses. Sequentially, it rose 28.0% from the prior quarter. Over 3 fiscal years it compounded at -25.7% a year.
Context
- Operating expenses amounted to 24.4% of revenue in FY2026, down 1.8 pp from a year earlier.
- Operating expenses increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +32.0% holds above the trailing-twelve-month pace of +1.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2026
- 265.23M USD
- Year-over-year change
- -10.9%
- 4-year CAGR
- -2.3%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 265.23M | -10.9% |
| FY2025 | 2025-03-31 | 297.69M | +5.6% |
| FY2024 | 2024-03-31 | 282.02M | -56.5% |
| FY2023 | 2023-03-31 | 647.71M | +122.8% |
| FY2022 | 2022-03-31 | 290.73M | — |
Operating Expenses vs competitors
How PBH compares with its peers on the latest reported figures
- PBH's LTM Jun 2026 operating expenses of $298.32M is the 7th highest of the 11 companies compared; the peer median is $410.56M.
- Its year-over-year change of +1.9% is the 5th highest of 11, against a peer median of +0.3%.
- Operating expenses amounts to 27.0% of revenue for PBH, versus a peer median of 54.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $850.62M | +16.5% | -1.9% | 56.5% | |
| LTM Sep 2026 | $740.02M | -0.1% | +14.3% | 54.5% | |
| LTM Jun 2026 | $702.41M | -10.0% | -1.3% | 32.5% | |
| LTM Mar 2026 | $570.57M | -1.6% | +17.3% | 72.5% | |
| LTM Jun 2026 | $517.9M | +0.8% | -3.3% | 115.2% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $303.23M | +12.7% | +23.0% | 13.0% |
| LTM Jun 2026 | $298.32M | +1.9% | -25.7% | 27.0% | |
HTFLHeartflow, Inc. Common Stock | LTM Sep 2026 | $266.85M | +44.4% | — | 111.8% |
IRONDisc Medicine, Inc. | LTM Sep 2026 | $265.73M | +30.5% | +70.7% | — |
| LTM Mar 2026 | $223.79M | -2.3% | +46.3% | 37.5% | |
| LTM Jun 2026 | $134.59M | -19.5% | +4.4% | 5.7% | |
| Peer median (excluding PBH) | $410.56M | +0.3% | +14.3% | 54.5% | |
Competitors are the stored peer set for PBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 1.09B | 1.13B | 1.13B | 1.14B | 1.09B |
| Cost of Revenue | 466.17M | 502.43M | 500.91M | 503.3M | 514.07M |
| Gross Profit | 620.65M | 625.29M | 624.45M | 634.46M | 574.64M |
| Gross Margin | 57.1% | 55.4% | 55.5% | 55.8% | 52.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 264.8M | 252.42M | 259.47M | 263.93M | 265.23M |
| Operating Expenses | 290.73M | 647.71M | 282.02M | 297.69M | 265.23M |
| Depreciation & Amortization | 32.09M | 32.63M | 30.68M | 30.17M | 31.27M |
| EBITDA | 358.84M | 7.87M | 373.86M | 361.99M | 331.11M |
| EBITDA Margin | 33.0% | 0.7% | 33.2% | 31.8% | 30.4% |
| Operating Income | 329.92M | (22.42M) | 342.43M | 336.78M | 309.41M |
| Operating Margin | 30.4% | -2.0% | 30.4% | 29.6% | 28.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 64.29M | 69.16M | 67.16M | 47.63M | 42.34M |
| Other Income / Expenses | (67.46M) | (71.5M) | (66.4M) | (52.59M) | (51.91M) |
| Income Before Tax | 262.46M | (93.92M) | 276.03M | 284.19M | 257.5M |
| Pre-Tax Margin | 24.1% | -8.3% | 24.5% | 25.0% | 23.7% |
| Income Tax Expense | 57.08M | (11.61M) | 66.69M | 69.58M | 67.2M |
| Net Income | 205.38M | (82.31M) | 209.34M | 214.61M | 190.3M |
| Net Margin | 18.9% | -7.3% | 18.6% | 18.9% | 17.5% |
| EPS (Basic) | 4.09 | (1.65) | 4.21 | 4.32 | 3.93 |
| EPS (Diluted) | 4.04 | (1.65) | 4.17 | 4.29 | 3.91 |
| Weighted Avg Shares | 50.26M | 49.88M | 49.76M | 49.7M | 48.46M |
| Weighted Avg Shares (Diluted) | 50.84M | 49.89M | 50.18M | 50.08M | 48.72M |
Prestige Consumer Healthcare Inc.
NYSE:PBH
Intrinsic Alpha fair value
Locked
Current Price
$50.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.